These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17006454)

  • 1. Alpha-interferon for relapsed non-Hodgkin's lymphoma.
    Armitage AE; Armitage JD; Armitage JO
    Bone Marrow Transplant; 2006 Nov; 38(10):701-2. PubMed ID: 17006454
    [No Abstract]   [Full Text] [Related]  

  • 2. An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma.
    Miglino M; Pierri I; Canepa L; Carrara P; Celesti L; Gobbi M
    Haematologica; 1993; 78(6):411-3. PubMed ID: 8175038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon in the treatment of non-Hodgkin's lymphoma].
    Mantovani L; Guglielmi C; Martelli M; Lombardi A; Mandelli F
    Clin Ter; 1988 Oct; 127(2):123-30. PubMed ID: 2976348
    [No Abstract]   [Full Text] [Related]  

  • 5. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and feasibility of IDEA therapy for refractory or relapsed non-Hodgkin's lymphoma.
    Nishimori H; Fujii N; Maeda Y; Matsuoka K; Takenaka K; Shinagawa K; Ikeda K; Matsuo K; Harada M; Tanimoto M
    Anticancer Res; 2009 May; 29(5):1749-54. PubMed ID: 19443398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
    Aydin S; Dührsen U; Nückel H
    Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage radiotherapy in patients with PET-Positive residual non-Hodgkin's lymphoma after chemotherapy: in regard to Kahn et al. (Int J Radiat Oncol Biol Phys 2006;66:961-965).
    Nieder C; Andratschke N
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1278; author reply 1278. PubMed ID: 17336228
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage chemotherapy with dexamethasone, etoposide, ifosfamide and cisplatin (DVIP) for relapsing and refractory non-Hodgkin's lymphoma.
    Lazar AD; Shpilberg O; Shaklai M; Bairey O
    Isr Med Assoc J; 2009 Jan; 11(1):16-22. PubMed ID: 19344007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
    Tsunoda S; Kobayashi H; Inoue K; Izumi T; Akutsu M; Katano S; Ueda T; Shirai T; Masuda Y; Ohmine K; Nagashima T; Ueda M; Takagi S; Muroi K; Ozawa K; Kano Y
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):885-9. PubMed ID: 17565251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
    Bo LJ; Liang AB; Liu B; Chen YH; Wang F; Jin XP
    Ai Zheng; 2006 Dec; 25(12):1553-6. PubMed ID: 17166385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-interferon in the treatment of malignant lymphoma.
    Cavalli F
    Br J Clin Pract Suppl; 1988 Mar; 62():16-21. PubMed ID: 3145009
    [No Abstract]   [Full Text] [Related]  

  • 13. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Wiernik PH; Lossos IS; Tuscano JM; Justice G; Vose JM; Cole CE; Lam W; McBride K; Wride K; Pietronigro D; Takeshita K; Ervin-Haynes A; Zeldis JB; Habermann TM
    J Clin Oncol; 2008 Oct; 26(30):4952-7. PubMed ID: 18606983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable low IgG levels in relapsed non-Hodgkin's lymphomas.
    Buda G; Galimberti S; Orciuolo E; Caracciolo F; Cecconi N; Gasparini M; Petrini M
    Ann Hematol; 2007 Nov; 86(11):851-3. PubMed ID: 17541588
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
    Leonard JP; Link BK; Emmanouilides C; Gregory SA; Weisdorf D; Andrey J; Hainsworth J; Sparano JA; Tsai DE; Horning S; Krieg AM; Weiner GJ
    Clin Cancer Res; 2007 Oct; 13(20):6168-74. PubMed ID: 17947483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of invasive non-Hodgkin's lymphoma].
    Yu H; Hong XN; Li J; Peng LP; Ye L
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma.
    Sieniawski M; Staak O; Glossmann JP; Reineke T; Scheuss H; Diehl V; Engert A; Josting A
    Ann Hematol; 2007 Feb; 86(2):107-15. PubMed ID: 17103169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
    Hauswirth AW; Skrabs C; Schützinger C; Raderer M; Chott A; Valent P; Lechner K; Jäger U
    Haematologica; 2008 Mar; 93(3):447-50. PubMed ID: 18287133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma.
    De Renzo A; Perna F; Persico M; Notaro R; Mainolfi C; de Sio I; Ciancia G; Picardi M; Del Vecchio L; Pane F; Rotoli B
    Eur J Haematol; 2008 Jul; 81(1):51-7. PubMed ID: 18397390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.